Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$45.1M |
| 2 |
Cisco
CSCO
|
+$38.8M |
| 3 |
Oracle
ORCL
|
+$37M |
| 4 |
DuPont de Nemours
DD
|
+$36.5M |
| 5 |
Eli Lilly
LLY
|
+$30.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$61.2M |
| 2 |
Wells Fargo
WFC
|
+$52.2M |
| 3 |
Amazon
AMZN
|
+$49.5M |
| 4 |
Chemours
CC
|
+$49.3M |
| 5 |
Pfizer
PFE
|
+$44.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.09% |
| 2 | Industrials | 17.32% |
| 3 | Healthcare | 15.49% |
| 4 | Consumer Discretionary | 13.3% |
| 5 | Consumer Staples | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Seagate
STX
$193B
| $10.1M | 0.16% |
214,807
-237,993
| -53% | -$11.1M |
|
177
Packaging Corp of America
PKG
$22.5B
| $10.1M | 0.16% |
105,876
+56,246
| +113% | +$5.43M |
|
178
LivaNova
LIVN
$4.34B
| $10M | 0.16% |
139,583
+14,557
| +12% | +$1.07M |
|
|
AGN
179
DELISTED
Allergan plc
AGN
| $10M | 0.16% |
+59,828
| New | +$8.28M |
|
180
Steris
STE
$23.2B
| $9.92M | 0.16% |
66,657
-1,822
| -3% | -$243K |
|
181
Ametek
AME
$54.9B
| $9.79M | 0.16% |
107,798
+55,206
| +105% | +$4.73M |
|
182
Walt Disney
DIS
$186B
| $9.75M | 0.16% |
69,851
-206,153
| -75% | -$27.3M |
|
|
HBI
183
DELISTED
Hanesbrands
HBI
| $9.64M | 0.15% |
559,755
-294,085
| -34% | -$5.07M |
|
|
184
Wells Fargo
WFC
$254B
| $9.55M | 0.15% |
201,794
-1,115,710
| -85% | -$52.2M |
|
185
Roper Technologies
ROP
$40.7B
| $9.54M | 0.15% |
+26,045
| New | +$9.24M |
|
186
C.H. Robinson
CHRW
$16.5B
| $9.45M | 0.15% |
111,989
+16,312
| +17% | +$1.37M |
|
187
NRG Energy
NRG
$23.8B
| $9.34M | 0.15% |
265,856
+126,533
| +91% | +$4.77M |
|
188
Ionis Pharmaceuticals
IONS
$9.93B
| $9.33M | 0.15% |
145,190
+133,840
| +1,179% | +$9.46M |
|
189
Danaher
DHR
$154B
| $9.33M | 0.15% |
73,608
-7,068
| -9% | -$837K |
|
190
Ingersoll Rand
IR
$31.2B
| $9.32M | 0.15% |
269,284
-64,445
| -19% | -$2.08M |
|
191
Amdocs
DOX
$6.41B
| $9.27M | 0.15% |
149,314
+97,504
| +188% | +$5.63M |
|
192
Open Text
OTEX
$5.97B
| $9.25M | 0.15% |
224,545
+41,838
| +23% | +$1.67M |
|
193
Mattel
MAT
$4.15B
| $9.2M | 0.15% |
820,494
+362,331
| +79% | +$4.26M |
|
|
JNPR
194
DELISTED
Juniper Networks
JNPR
| $9.15M | 0.15% |
343,743
-228,399
| -40% | -$6.11M |
|
195
Textron
TXT
$14.3B
| $8.97M | 0.14% |
169,216
-40,183
| -19% | -$2.04M |
|
196
Salesforce
CRM
$171B
| $8.93M | 0.14% |
58,864
+41,139
| +232% | +$6.45M |
|
|
CDK
197
DELISTED
CDK Global, Inc.
CDK
| $8.88M | 0.14% |
179,680
+4,432
| +3% | +$237K |
|
198
Landstar System
LSTR
$6.33B
| $8.77M | 0.14% |
81,236
+23,027
| +40% | +$2.46M |
|
199
Delek US
DK
$4.38B
| $8.74M | 0.14% |
215,696
+135,563
| +169% | +$4.96M |
|
200
Medpace
MEDP
$17.3B
| $8.56M | 0.14% |
130,892
-5,658
| -4% | -$326K |
|
Similar funds
Joel Greenblatt's Q2 2019 Portfolio in Review
As of Q2 2019, Joel Greenblatt held 1,366 positions worth $6.27B, down 8.2% from $6.83B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Joel Greenblatt withdrew a net $642M in Q2 2019, closing 251 positions and reducing 489 holdings. Its most notable exit was Chemours, an estimated $49.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Intuit worth $46.3M.
- Joel Greenblatt's largest Q2 2019 buy was Intuit: 177,339 shares worth $46.3M.
- Joel Greenblatt added most to Cisco in Q2 2019, an estimated $38.8M increase.
- Joel Greenblatt's biggest Q2 2019 reduction was PayPal, cutting an estimated $61.2M.
- Joel Greenblatt fully exited Chemours in Q2 2019, selling an estimated $49.3M.
- Joel Greenblatt's ten largest holdings make up 10% of its $6.27B portfolio in Q2 2019.
- Joel Greenblatt opened 206 new positions and closed 251 in Q2 2019.
- Joel Greenblatt's portfolio value fell 8.2% quarter-over-quarter to $6.27B.
Based on Gotham Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.